A patient with benzodiazepine use disorder is being tapered using a long-acting agent. What is the clinical rationale for using a long-acting benzodiazepine like diazepam for taper?
-
A
Long-acting agents have a stronger euphoric effect, reducing cravings more effectively
-
B
The prolonged half-life produces a smoother, self-tapering effect that reduces withdrawal severity
-
C
Long-acting agents are safer because they do not affect GABA receptors
-
D
They are preferred because they can be administered intramuscularly